In the BioHarmony Drug Report Database
Paricalcitol
Paricalcitol, Zemplar (paricalcitol) is a small molecule pharmaceutical. Paricalcitol was first approved as Paricalcitol on 1998-04-17. It is used to treat hyperparathyroidism in the USA. The pharmaceutical is active against vitamin D3 receptor.
Trade Name
|
Paricalcitol, Zemplar |
|---|---|
Common Name
|
paricalcitol |
ChEMBL ID
|
CHEMBL1200622 |
Indication
|
hyperparathyroidism |
Drug Class
|
Vitamin D analogues |
Image (chem structure or protein)